- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human alkaline phosphatase
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human alkaline phosphatase
| EU orphan designation number: | EU/3/14/1427
|
| Active ingredient: | Recombinant human alkaline phosphatase |
| Indication: | Treatment of hypophosphatasia |
| Sponsor: | AM-Pharma BV
Rumpsterweg 6, 3891 AK Bunnik, Nederland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 19/01/2015 | Orphan designation | EMA/OD/218/14 | (2015)193 of 15/01/2015 |
CONTACT
EU links
Directorate General Health & Consumers